Zheng-tu Li
发表
Shaoqiang Li,
F. Ye,
Jing Wang,
2020,
Journal of medical virology.
Huaying Chen,
Chang Chen,
Yonggang Zhu,
2021,
Lab on a chip.
Zi-feng Yang,
Xinhua Wang,
Hongxia Ma,
2019,
BMJ Open.
Shaoqiang Li,
Jincun Zhao,
N. Zhong,
2020,
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
Shaoqiang Li,
F. Ye,
Zheng-tu Li,
2021,
Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.
Jingyi Liang,
Shiyue Li,
Zheng-tu Li,
2021,
International Journal of Infectious Diseases.
Jingyi Liang,
Shiyue Li,
Zheng-tu Li,
2021,
Open forum infectious diseases.
P. Hu,
Zi-feng Yang,
Zheng-tu Li,
2017,
Molecules.
Shaoqiang Li,
Hui-zhi Chen,
Zheng-tu Li,
2020
.
Zi-feng Yang,
Zheng-tu Li,
Yunhui Zhang,
2018,
Journal of thoracic disease.
Honglin Chen,
Zi-feng Yang,
Wenjun Song,
2021,
Journal of thoracic disease.
Shi-yue Li,
N. Zhong,
Shaoqiang Li,
2020,
Journal of medical virology.
Rongchang Chen,
N. Zhong,
Zi-feng Yang,
2015,
Journal of ethnopharmacology.
Zi-feng Yang,
Zheng-tu Li,
Jicheng Huang,
2016
.
B. Cao,
Zi-feng Yang,
Zheng-tu Li,
2020
.
Shaoqiang Li,
F. Ye,
Lee-Fong Yau,
2021,
Frontiers in Cellular and Infection Microbiology.
Tanshinone IIA inhibits lipopolysaccharide-induced MUC1 overexpression in alveolar epithelial cells.
Chenting Zhang,
Zheng-tu Li,
Wenju Lu,
2014,
American journal of physiology. Cell physiology.
Rongchang Chen,
Chenting Zhang,
Zheng-tu Li,
2017,
Journal of thoracic disease.
Jincun Zhao,
S. Hyde,
D. Gill,
2022,
Frontiers in Immunology.
F. Ye,
Zheng-tu Li,
Yuzhuo Zhang,
2022,
Frontiers in Public Health.
Shaoqiang Li,
F. Ye,
Zheng-tu Li,
2022,
Emerging microbes & infections.
Shaoqiang Li,
F. Ye,
Weiqi Zeng,
2022,
BMC Infectious Diseases.
W. Guan,
Shaoqiang Li,
Zheng-tu Li,
2021,
Frontiers in Medicine.
Zi-feng Yang,
F. Ye,
Zheng-tu Li,
2022,
Frontiers in Pharmacology.
F. Ye,
Feng Cong,
Zheng-tu Li,
2022,
Frontiers in Microbiology.
W. Guan,
Shaoqiang Li,
F. Ye,
2022,
Infection and drug resistance.
Shaoqiang Li,
F. Ye,
Zheng-tu Li,
2022,
Frontiers in Public Health.
W. Guan,
Shaoqiang Li,
Zheng-tu Li,
2021,
BMC Infectious Diseases.
Shaoqiang Li,
N. Zhong,
F. Ye,
2021,
Emerging microbes & infections.
F. Ye,
Zheng-tu Li,
Y. Qiu,
2022,
Frontiers in Immunology.
Shaoqiang Li,
F. Ye,
Zheng-tu Li,
2022,
Frontiers in Cellular and Infection Microbiology.
W. Guan,
Rongchang Chen,
Shaoqiang Li,
2021,
Frontiers in Microbiology.
Xiao-Neng Mo,
Shaoqiang Li,
Jincun Zhao,
2021,
Journal of Genetics and Genomics.
Zheng-tu Li,
Zhen-ming Yang,
Y. Qiu,
2022,
BMC Infectious Diseases.
Emergence of triple-subtype reassortants of fatal human H5N6 avian influenza virus in Yunnan, China.
N. Zhong,
Zi-feng Yang,
Zheng-tu Li,
2016,
The Journal of infection.
Zi-feng Yang,
Zheng-tu Li,
Chunguang Yang,
2017,
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
Liyan Wen,
Lu Zhang,
Jingxian Zhao,
2020,
The Journal of clinical investigation.
N. Zhong,
Zi-feng Yang,
Zheng-tu Li,
2018,
Life sciences.
Bairong Shen,
Zheng-tu Li,
Wenlong Jia,
2022,
Computational and Structural Biotechnology Journal.
Yen Kaow Ng,
Bairong Shen,
Zheng-tu Li,
2021,
bioRxiv.
Shaoqiang Li,
Jincun Zhao,
N. Zhong,
2021,
Science China Life Sciences.
F. Ye,
Zheng-tu Li,
S. Li,
2020,
bioRxiv.
N. Zhong,
Chenting Zhang,
Zheng-tu Li,
2014,
European journal of immunology.
Shaoqiang Li,
F. Ye,
Zheng-tu Li,
2021,
Annals of translational medicine.